Keith Shaw Cardiothoracic Surgery Unit, CResT Directorate, St James's University Hospital, James's St, Dublin 8, Ireland.
Eur J Cardiothorac Surg. 2011 Jan;39(1):68-74. doi: 10.1016/j.ejcts.2010.05.043. Epub 2010 Jul 21.
Preoperative methicillin-resistant Staphylococcus aureus (MRSA) carriage is associated with higher rates of postoperative MRSA infection. Carriage can be eradicated but this requires delaying surgery, which presents a dilemma when the surgery is urgent. We analysed the incidence of preoperative MRSA carriage and the impact on postoperative outcomes in a cardiac surgery population.
Patient data were collected prospectively from 2000 to 2007 (n=3789). MRSA screening is performed at a preadmission clinic for elective patients and on admission to the hospital for all patients. Three groups of MRSA carriers were identified: patients who were identified as carriers at a preadmission clinic (n=22, group 1), patients whose admission screening was positive but where the result was received postoperatively (n=103, group 2) and patients who acquired an MRSA infection or colonisation more than 48 h after admission (n=60, group 3).
MRSA eradication measures prior to admission were successful in 21 of 22 in group 1 (95.4%). There were no MRSA infections in group 1. However, in group 2 there were 11 patients with an MRSA infection (10%) even though eradication measures were started on confirmation of carriage. In group 3, 19 of the 60 patients had an MRSA infection. The intensive care stay and mortality were significantly greater in groups 2 and 3 than in group 1 or compared with the overall patient population. However, groups 2 and 3 also had a significantly higher risk profile (European System for Cardiac Operative Risk Evaluation (EuroSCORE)). When matched with similar risk patients, patients in groups 2 and 3 had mortality outcomes that were consistent with matched risk patients.
Patients who were MRSA carriers were older, more likely to have been on haemodialysis and to have been admitted from another hospital and underwent more complex surgical procedures. Carriage of MRSA was associated with a very high rate of MRSA infection, particularly among patients with diabetes. This suggests that delaying surgery may be warranted in patients expected to require implantation of prosthetic material such as valves, especially with diabetes. However, the survival outcomes for MRSA carriers are determined by their EuroSCORE rather than their MRSA status. This suggests that urgent cardiac surgery should not be delayed in patients with MRSA carriage.
术前耐甲氧西林金黄色葡萄球菌(MRSA)携带与术后 MRSA 感染率较高有关。可以消除携带,但这需要延迟手术,而当手术紧急时,这就带来了一个困境。我们分析了心脏手术患者人群中的术前 MRSA 携带情况及其对术后结果的影响。
2000 年至 2007 年期间前瞻性收集患者数据(n=3789)。择期患者在入院前诊所进行 MRSA 筛查,所有患者在入院时进行筛查。确定了三组 MRSA 携带者:在入院前诊所被确定为携带者的患者(n=22,第 1 组)、入院筛查阳性但结果在术后获得的患者(n=103,第 2 组)和入院 48 小时后获得 MRSA 感染或定植的患者(n=60,第 3 组)。
第 1 组 22 例患者中有 21 例(95.4%)在入院前成功进行了 MRSA 消除措施。第 1 组无 MRSA 感染。然而,第 2 组有 11 例患者发生 MRSA 感染(10%),尽管在确认携带后已开始消除措施。第 3 组 60 例患者中有 19 例发生 MRSA 感染。与第 1 组或与总体患者人群相比,第 2 组和第 3 组的重症监护时间和死亡率显著更高。然而,第 2 组和第 3 组的风险状况也明显更高(欧洲心脏手术风险评估系统(EuroSCORE))。当与具有相似风险的患者匹配时,第 2 组和第 3 组患者的死亡率与匹配风险患者一致。
MRSA 携带者年龄较大,更有可能接受血液透析,并且更有可能从其他医院入院,并接受更复杂的手术。MRSA 携带与非常高的 MRSA 感染率相关,尤其是在糖尿病患者中。这表明,对于需要植入假体材料(如瓣膜)的患者,可能需要延迟手术,尤其是对于糖尿病患者。然而,MRSA 携带者的生存结果取决于他们的 EuroSCORE,而不是他们的 MRSA 状态。这表明,对于携带 MRSA 的心脏手术患者,不应延迟紧急手术。